Researchers and physicians at the Transcatheter Cardiovascular Therapeutics symposium discuss renal denervation in helping alleviate symptoms of everything from congestive heart failure to obstructive sleep apnea.
Renal denervation may have lost some of its hype over the course of the last year, but researchers are still findings new ways to utilize the technology to target new diseases.
Technologies such as Medtronic’s (NYSE:MDT) Symplicity and St. Jude Medical’s (NYSE:STJ) EnligHTN systems, developed in treatment of hypertension, may have applications in ailments randing from chronic kidney disease to obstructive sleep apnea.